Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22:1342–56.
Article
Google Scholar
Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476–86.
Article
Google Scholar
Jones NR, Roalfe AK, Adoki I, Hobbs FDR, Taylor CJ. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. 2019;21(11):1306–25.
Article
Google Scholar
Jackson SL, Tong X, King RJ, Loustalot F, Hong Y, Ritchey MD. National Burden of heart failure events in the United States, 2006 to 2014. Circ Heart Fail. 2018;11(12): e004873. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004873.
Article
PubMed
PubMed Central
Google Scholar
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: a report From the American Heart Association. Circulation. 2018;137(12):e67–492. https://doi.org/10.1161/CIR.0000000000000558.
Article
PubMed
Google Scholar
Rossignol P, Hernandez AF, Solomon SD, Zannad F. Heart failure drug treatment. Lancet. 2019;393(10175):1034–44.
CAS
Article
Google Scholar
World Health Organization. International drug monitoring. The role of the hospital. World Health Organ Tech Rep Ser. 1969;425:5–24.
Google Scholar
McNallan SM, Singh M, Chamberlain AM, Kane RL, Dunlay SM, Redfield MM, et al. Frailty and healthcare utilization among patients with heart failure in the community. JACC Heart Fail. 2013;1(2):135–41.
Article
Google Scholar
Yang X, Lupon J, Vidan MT, Ferguson C, Gastelurrutia P, Newton PJ, et al. Impact of frailty on mortality and hospitalization in chronic heart failure: a systematic review and meta-analysis. J Am Heart Assoc. 2018;7(23): e008251. https://doi.org/10.1161/JAHA.117.008251.
Article
PubMed
PubMed Central
Google Scholar
Catananti C, Liperoti R, Settanni S, Lattanzio F, Bernabei R, Fialova D, et al. Heart failure and adverse drug reactions among hospitalized older adults. Clin Pharm Ther. 2009;86(3):307–10.
CAS
Article
Google Scholar
Hanlon P, Butterly E, Lewsey J, Siebert S, Mair FS, McAllister DA. Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions. BMC Med. 2020;18(1):309.
CAS
Article
Google Scholar
Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31(4):199–205.
CAS
Article
Google Scholar
Duong MH, Gnjidic D, McLachlan AJ, Sakiris MA, Goyal P, Hilmer SN. The Prevalence of Adverse Drug Reactions or Adverse Drug Events with Heart Failure Management in Frail Older Adults: A Systematic Review and Meta-Analysis. PROSPERO: International prospective register of systematic reviews [cited 2022 Jan 31]. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=253762.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178–89.
Article
Google Scholar
Golder S, Peryer G, Loke YK. Overview: comprehensive and carefully constructed strategies are required when conducting searches for adverse effects data. J Clin Epidemiol. 2019;113:36–43.
Article
Google Scholar
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–6.
Article
Google Scholar
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.
CAS
Article
Google Scholar
Mitnitski AB, Song X, Rockwood K. The estimation of relative fitness and frailty in community-dwelling older adults using self-report data. J Gerontol A Biol Sci Med Sci. 2004;59(6):M627–32.
Article
Google Scholar
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.
Article
Google Scholar
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:4919. Doi: https://doi.org/10.1136/bmj.i4919.
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.
Article
Google Scholar
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ, et al. What is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336(7651):995–8.
Article
Google Scholar
Ekerstad N, Bylin K, Karlson BW. Early rehospitalizations of frail elderly patients - the role of medications: a clinical, prospective, observational trial. Drug Healthc Patient Saf. 2017;9:77–88.
CAS
Article
Google Scholar
Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722–7.
Article
Google Scholar
Dewan P, Jackson A, Jhund PS, Shen L, Ferreira JP, Petrie MC, et al. The prevalence and importance of frailty in heart failure with reduced ejection fraction—an analysis of PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2020;22(11):2123–33.
Article
Google Scholar
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004.
Article
Google Scholar
McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, et al. Aliskiren, enalapril, or aliskiren and enalapril in heart failure. N Engl J Med. 2016;374(16):1521–32.
CAS
Article
Google Scholar
Vidán MT, Blaya-Novakova V, Sánchez E, Ortiz J, Serra-Rexach JA, Bueno H. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail. 2016;18(7):869–75.
Article
Google Scholar
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharm Ther. 1981;30(2):239–45.
CAS
Article
Google Scholar
Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.
CAS
Article
Google Scholar
Caughey GE, Inacio MC, Bell JS, Vitry AI, Shakib S. Inclusion of older people reflective of real-world clinical practice in cardiovascular drug trials. J Am Heart Assoc. 2020;9(21): e016936. https://doi.org/10.1161/JAHA.120.016936.
Article
PubMed
PubMed Central
Google Scholar
Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171(6):550–6.
Article
Google Scholar
Wang X, Zhou C, Li Y, Li H, Cao Q, Li F. Prognostic value of frailty for older patients with heart failure: a systematic review and meta-analysis of prospective studies. BioMed Res Int. 2018. https://doi.org/10.1155/2018/8739058.
Article
PubMed
PubMed Central
Google Scholar
Lien CT, Gillespie ND, Struthers AD, McMurdo ME. Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polypharmacy and treatment dilemmas. Eur J Heart Fail. 2002;4:91–8.
Article
Google Scholar
Desai AS, Solomon S, Claggett B, McMurray JJ, Rouleau J, Swedberg K, et al. Factors associated with noncompletion during the run-in period before randomization and influence on the estimated benefit of LCZ696 in the PARADIGM-HF trial. Circ Heart Fail. 2016;9(6): e002735. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002735.
Article
PubMed
Google Scholar
Uchmanowicz I, Młynarska A, Lisiak M, Kałużna-Oleksy M, Wleklik M, Chudiak A, et al. Heart failure and problems with frailty syndrome: why it is time to care about frailty syndrome in heart failure. Card Fail Rev. 2019;5(1):37–43.
Article
Google Scholar
Purser JL, Kuchibhatla MN, Fillenbaum GG, Harding T, Peterson ED, Alexander KP. Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc. 2006;54:1674–81.
Article
Google Scholar
Sanders NA, Supiano MA, Lewis EF, Liu J, Claggett B, Pfeffer MA, et al. The frailty syndrome and outcomes in the TOPCAT trial. Eur J Heart Fail. 2018;20(11):1570–7.
CAS
Article
Google Scholar
Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7.
Article
Google Scholar
Zorzela L, Golder S, Liu Y, Pilkington K, Hartling L, Joffe A, et al. Quality of reporting in systematic reviews of adverse events: systematic review. BMJ. 2014;348: f7668. https://doi.org/10.1136/bmj.f7668.
Article
PubMed
PubMed Central
Google Scholar
Caughey GE, Shakib S, Barratt JD, Roughead EE. Use of medicines that may exacerbate heart failure in older adults: therapeutic complexity of multimorbidity. Drugs Aging. 2019;36(5):471–9.
Article
Google Scholar
Murray NP, Daly MJ. Gynecomastia and heart failure-adverse drug reaction or disease process? J Clin Pharm Ther. 1991;16(4):275–9.
CAS
Article
Google Scholar
Sztramko R, Chau V, Wong R. Adverse drug events and associated factors in heart failure therapy among the very elderly. Can Geriatr J. 2011;14(4):79–92.
Article
Google Scholar
Goyal P, Yum B, Navid P, Chen L, Kim DH, Roh J, et al. Frailty and post-hospitalization outcomes in patients with heart failure with preserved ejection fraction. Am J Cardiol. 2021;148:84–93.
Article
Google Scholar
Martín-Sánchez FJ, Christ M, Miró Ò, Peacock WF, McMurray JJ, Bueno H, et al. Practical approach on frail older patients attended for acute heart failure. Int J Cardiol. 2016;222:62–71.
Article
Google Scholar
Pulignano G, Del Sindaco D, Di Lenarda A, Tarantini L, Cioffi G, Gregori D, et al. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. J Cardiovasc Med. 2010;11:739–47.
Article
Google Scholar
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–1032. https://doi.org/10.1161/CIR.0000000000001063.
Article
PubMed
Google Scholar
van der Wal MH, Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol. 2008;125(2):203–8.
Article
Google Scholar
Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar-Jacob JM. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J Am Heart Assoc. 2016;5(6):17.
Article
Google Scholar
Teixeira A, Arrigo M, Tolppanen H, Gayat E, Laribi S, Metra M, et al. Management of acute heart failure in elderly patients. Arch Cardiovasc Dis. 2016;109(6–7):422–30.
Article
Google Scholar